The chip supplier spent about $100 million on its Cambridge-1 system, which uses artificial intelligence to solve health research problems and was announced in October. In the case of AstraZeneca, for example, the system will learn about 1 billion chemical compounds represented by groups of characters that can be assembled into sentence-like structures.
from Gadgets Now https://ift.tt/36mSyra
Wednesday, July 7, 2021
Nvidia gives health researchers access to UK supercomputer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment